Codes / ICD10CM / T46.6X5

T46.6X5 Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs

Summary

This condition describes unintended negative reactions resulting from the use of medications designed to lower lipid levels or prevent arteriosclerosis. These drugs, such as statins or fibrates, are commonly prescribed to manage cholesterol and reduce cardiovascular risk, but adverse effects can occur during treatment.

Causes

The condition is caused by the body’s response to antihyperlipidemic or antiarteriosclerotic drugs, which may trigger reactions at therapeutic doses. These reactions are not due to overdose or underdosing but arise from individual sensitivity or drug-specific effects.

Risk Factors

  • First-time use of antihyperlipidemic or antiarteriosclerotic medications.
  • Pre-existing liver or kidney impairment.
  • Concurrent use of interacting drugs.
  • Personal or family history of drug allergies.
  • Advanced age or certain genetic factors.

Symptoms

  • Muscle pain or weakness (myopathy).
  • Elevated liver enzymes or liver dysfunction.
  • Gastrointestinal issues like nausea or diarrhea.
  • Allergic reactions, including rashes or itching.
  • Neurological symptoms such as memory changes or confusion.

Diagnosis

Diagnosis involves reviewing the patient’s medication history and symptoms. Blood tests, including liver function tests and creatine kinase levels, assess organ involvement. Physical examination evaluates muscle strength and signs of allergic reactions.

Treatment Options

  • Discontinuation or substitution of the offending drug.
  • Supportive care, such as rest or hydration, to manage symptoms.
  • Medications like antihistamines for allergic reactions.
  • Monitoring of liver and muscle function during recovery.

Prognosis and Follow-Up

Most adverse effects resolve with drug adjustment or discontinuation. Follow-up includes monitoring for symptom resolution and repeat testing if needed. Long-term prognosis depends on the severity of the reaction and any underlying conditions.

Complications

  • Persistent muscle damage (rhabdomyolysis) in severe cases.
  • Chronic liver dysfunction.
  • Recurrent allergic reactions with re-exposure.
  • Delayed or inadequate lipid management if treatment is interrupted.

Lifestyle & Prevention

  • Inform healthcare providers of all medications and allergies before starting new drugs.
  • Follow prescribed dosing and report symptoms promptly.
  • Maintain regular monitoring of liver and muscle function as advised.
  • Discuss alternative therapies if adverse effects occur.

When to Seek Professional Help

Seek immediate care for severe symptoms like intense muscle pain, jaundice, or difficulty breathing. Contact a provider for persistent or worsening symptoms, such as ongoing nausea, fatigue, or unexplained rashes.

Tips for Medical Coders

This code (T46.6X5) is used for adverse effects of antihyperlipidemic and antiarteriosclerotic drugs. Document the specific drug involved, the nature of the adverse effect, and any resulting complications. Ensure the encounter type (e.g., initial, subsequent) is accurately reflected in the code selection.

Book a walkthrough

T46.6X5 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.